Woodline Partners’s MacroGenics MGNX Stock Holding History

Woodline Partners’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-188,711	Closed	-$228K	–	986
2025 Q2	$228K	Hold	188,711	–	–	﹤0.01%	901
2025 Q1	$240K	Hold	188,711	–	–	﹤0.01%	870
2024 Q4	$613K	Hold	188,711	–	–	﹤0.01%	814
2024 Q3	$621K	Sell	188,711 -180,831	-49%	-$704K	0.01%	527
2024 Q2	$1.57M	Buy	369,542 +4,117	+1%	+$40.1K	0.02%	438
2024 Q1	$5.38M	Buy	+365,425	New	+$5.52M	0.05%	349
2023 Q4	–	Sell	-364,700	Closed	-$1.7M	–	588
2023 Q3	$1.7M	Hold	364,700	–	–	0.02%	411
2023 Q2	$1.95M	Buy	+364,700	New	+$2.25M	0.02%	436
2022 Q4	–	Sell	-269,272	Closed	-$932K	–	813
2022 Q3	$932K	Hold	269,272	–	–	0.01%	542
2022 Q2	$794K	Hold	269,272	–	–	0.01%	536
2022 Q1	$2.37M	Hold	269,272	–	–	0.04%	361
2021 Q4	$4.32M	Sell	269,272 -556,397	-67%	-$10.5M	0.06%	306
2021 Q3	$17.3M	Buy	825,669 +580,073	+236%	+$14M	0.28%	102
2021 Q2	$6.6M	Buy	+245,596	New	+$7.19M	0.12%	191

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Woodline Partners's MGNX Position: Q3 2025 in Review

Woodline Partners sold out of MacroGenics (MGNX) in Q3 2025, closing a stake of 188,711 shares — an estimated $228K sold.

Woodline Partners first reported a position in MGNX in Q2 2021 and held it in 14 quarters. The position peaked at $17.3M in Q3 2021. 104 funds tracked by Wall St. Rank hold MGNX as of Q3 2025.

Woodline Partners reported no remaining MacroGenics position as of Q3 2025 after selling out during the quarter.
Woodline Partners sold 188,711 MacroGenics shares in Q3 2025, an estimated $228K.
Woodline Partners first reported a position in MacroGenics in Q2 2021 and held it in 14 quarters.
Woodline Partners's MacroGenics position peaked at $17.3M in Q3 2021.
104 funds tracked by Wall St. Rank held MacroGenics as of Q3 2025.

Based on Woodline Partners's 13F filing for Q3 2025, filed 14 Nov 2025.